Spyre Therapeutics, Inc. (SYRE)
NASDAQ: SYRE · Real-Time Price · USD
30.58
-2.18 (-6.65%)
At close: Jan 2, 2026, 4:00 PM EST
30.58
0.00 (0.00%)
After-hours: Jan 2, 2026, 4:10 PM EST
Spyre Therapeutics Market Cap
Spyre Therapeutics has a market cap or net worth of $2.37 billion as of January 2, 2026. Its market cap has increased by 91.28% in one year.
Market Cap
2.37B
Enterprise Value
1.89B
1-Year Change
91.28%
Ranking
Category
Stock Price
$30.58
Market Cap Chart
Since April 7, 2016, Spyre Therapeutics's market cap has increased from $111.70M to $2.37B, an increase of 2,024.23%. That is a compound annual growth rate of 36.86%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 2.54B | 112.30% |
| Dec 31, 2024 | 1.20B | 1,274.63% |
| Dec 29, 2023 | 87.10M | 214.44% |
| Dec 30, 2022 | 27.70M | -88.18% |
| Dec 31, 2021 | 234.30M | -37.90% |
| Dec 31, 2020 | 377.30M | 70.42% |
| Dec 31, 2019 | 221.40M | 23.34% |
| Dec 31, 2018 | 179.50M | 99.44% |
| Dec 29, 2017 | 90.00M | 54.11% |
| Dec 30, 2016 | 58.40M | -47.72% |
| Apr 7, 2016 | 111.70M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 955.83B |
| Johnson & Johnson | 498.24B |
| AbbVie | 405.93B |
| UnitedHealth Group | 305.96B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 262.97B |
| Novo Nordisk | 227.63B |